近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1．Lu S, Wei J, Sun F, Xiao W, Cai R, Zhen Z, Zhu J, Wang J, Huang J, Lu L, Sun X, Gao Y（通信作者）. Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors after Radiotherapy. Int J Radiat Oncol Biol Phys. 2018 Sep 20. pii: S0360-3016(18)33762-3. [Epub ahead of print] 2．Chang H, Wei JW, Chen K, Zhang S, Han F, Lu LX, Xiao WW, Gao YH（通信作者）. Apolipoprotein A-I Is a Prognosticator of Nasopharyngeal Carcinoma in the Era of Intensity-modulated Radiotherapy. J Cancer. 2018 Jan 11; 9(4): 702-710. 3．Wei J, Feng H, Xiao W, Wang Q, Qiu B, Liu S, Deng M, Lu L, Chang H, Gao Y（通信作者）. Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma. Chin J Cancer Res. 2018 Feb; 30(1): 51-60. 4．Lu S, Chang H, Sun X, Zhen Z, Sun F, Zhu J, Wang J, Huang J, Liao R, Guo X, Lu L, Gao Y（通信作者）. Long-Term Outcomes of Nasopharyngeal Carcinoma in 148 Children and Adolescents. Medicine. 2016 Apr; 95(17): e3445. (IF: 5.723) 5．Zhang LN, Gao YH（硕导第二）, Lan XW, Tang J, Su Z, Ma J, Deng W, OuYang PY, Xie FY. Propensity score matching analysis of cisplatin-based concurrent chemotherapy in low risk nasopharyngeal carcinoma in the intensity-modulated radiotherapy era. Oncotarget. 2015, 6(41): 44019-29. 6．Lu-Ning Zhang, Yuan-Hong Gao（共同第一）, Xiao-Wen Lan, Jie Tang, Pu-Yun OuYang, Fang-Yun Xie. Effect of taxanes-based induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A large scale propensity-matched study. Oral Oncol. 2015, 51(10): 950–956. 7．Ren YF, Gao YH (共同第一), Cao XP, Ye WJ, Teh BS. 3D-CT implanted interstitial brachytherapy for T2b nasopharyngeal carcinoma. Radiat Oncol. 2010. 5: 113-116. (IF: 2.381) 11．Jiawang Wei, Rong huang, suping Guo, Xuhui Zhang, Shaoyan Xi, Qiaoxuan Wang, Hui Chang, Xiaohao Wang, Weiwei Xiao, Zhifan Zeng, Yuanhong Gao(通信作者）. ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Cancer Management and Research. 2018, 10: 5219–5225. 12．Hu YH, Wei JW, Chang H, Xiao WW, Lin JZ, Cai MY, Cai PQ, Kong LH, Chen G, Pan ZZ, Zeng ZF, Ding PR, Gao YH(通信作者）. The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term urvival benefit: 5-year outcome of a Phase II clinical trial. Cancer Manag Res. 2018 Oct 10; 10: 4363-4369. 13．Chang H, Jiang W, Ye WJ, Tao YL, Wang QX, Xiao WW, Gao Y(通信作者）. Is long intervalfrom neoadjuvant chemoradiotherapy to surgery optimal for rectal cancer in the era of intensity-modulated radiotherapy: a prospective observational study. Onco Targets Ther. 2018 Sep 21;11: 6129-6138. 14．Peng H, Wang C, Xiao W, Lin X, You K, Dong J, Wang Z, Yu X, Zeng Z, Zhou T, Gao Y(通信作者）, Wen B. Analysis of Clinical characteristics to predict pathologic complete response for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. J Cancer. 2018 Jun 23; 9(15): 2687-2692. 15．Xiao WW, Zhang LN, You KY, Huang R, Yu X, Chang H, Ding PR, Gao YH(通信作者）.The total number of lymph nodes harvested from pathological T3N0 rectal cancer patients: Prognostic significance and potential indication for postoperative radiotherapy. J Cancer Res Ther. 2018 Jun; 14(Supplement): S288-S294. 16．Chang H, Yu X, Xiao WW, Wang QX, Zhou WH, Zeng ZF, Ding PR, Li LR, Gao YH(通信作者）. Neoadjuvant chemoradiotherapy followed by surgery in patients with unresectable locally advanced colon cancer: a prospective observational study. Onco Targets Ther. 2018 Jan 17; 11: 409-418. 17．Yu X, Wang QX, Xiao WW, Chang H, Zeng ZF, Lu ZH, Wu XJ, Chen G, Pan ZZ, Wan DS, Ding PR, Gao YH(通信作者）. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study. Cancer Commun (Lond). 2018 May 21; 38(1): 24. 18．Chang H, Wei JW, Tao YL, Ding PR, Xia YF, Gao YH(通信作者）, Xiao WW. CCR6 Is a Predicting Biomarker of Radiosensitivity and Potential Target of Radiosensitization in Rectal Cancer. Cancer Res Treat. 2018 Oct; 50(4): 1203-1213. 19．Xiao L, Yu X, Deng W, Feng H, Chang H, Xiao W, Zhang H, Xi S, Liu M, Zhu Y, Gao Y(通信作者）. Pathological Assessment of Rectal Cancer after Neoadjuvant Chemoradiotherapy: Distribution of Residual Cancer Cells and Accuracy of Biopsy. Sci Rep. 2016 Oct 10; 6:34923. doi: 10.1038/srep34923. 20．You KY, Huang R, Yu X, Liu YM, Gao YH (通信作者）. Is It Possible to Shorten the Duration of Adjuvant Chemotherapy for Locally Advanced Rectal Cancer? Medicine. 2016 Apr; 95(16): e3427.
京公网安备 11010802027423号